Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
Fernanda MoseleDepartment of Medical Oncology, Gustave Roussy, Villejuif, FranceJordi RemónDepartment of Medical Oncology, Centro Integral Oncológico Clara Campal (HM-CIOCC), Hospital HM Delfos, HM Hospitales, Barcelona, SpainJoaquı́n MateoClinical Research Program, Vall Hebron Institute of Oncology (VHIO) and Vall d'Hebron University Hospital, Barcelona, SpainC. Benedikt WestphalenLudwig-Maximilians-Universität MünchenFabrice BarlésiDepartment of Medical Oncology, Gustave Roussy, Villejuif, FranceMartijn P. LolkemaDepartment of Medical Oncology, Erasmus MC Cancer Center, Rotterdam, the NetherlandsNicola NormannoCell Biology and Biotherapy Unit, Istituto Nazionale Tumori, 'Fondazione G. Pascale' - IRCCS, Naples, ItalyAldo ScarpaARC-Net Research Centre and Department of Diagnostics and Public Health - Section of Pathology, University of Verona, Verona, ItalyMark E. RobsonBreast Medicine and Clinical Genetics Services, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USAFunda Meric‐BernstamDepartment of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, USANikhil WagleDana-Farber Cancer InstituteAlbrecht StenzingerUniversity Hospital HeidelbergJean-François BonastreOncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, FranceAriane BayleDepartment of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, FranceStefan MichielsDepartment of Biostatistics and Epidemiology, Gustave Roussy, University Paris-Saclay, Villejuif, France; Oncostat U1018, Inserm, University Paris-Saclay, labeled Ligue Contre le Cancer, Villejuif, FranceIvan BiècheInstitut CurieÉtienne RouleauCancer Genetic Laboratories, Department of Medical Biology and Pathology, Gustave Roussy Cancer Campus, Villejuif, FranceS. JezdicScientific and Medical Division, European Society for Medical Oncology, Lugano, SwitzerlandJ.-Y. DouillardScientific and Medical Division, European Society for Medical Oncology, Lugano, SwitzerlandJ.S. Reis-FilhoDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, USARodrigo DienstmannOncology Data Science Group, Molecular Prescreening Program, Vall d'Hebron Institute of Oncology, Barcelona, SpainFabrice AndréInserm, Gustave Roussy Cancer Campus, UMR981, Villejuif, France
2020en
Ochiq kirishGibrid
Litsenziya: other-oa
ABI
Annotatsiya
Annotatsiya mavjud emas.
Identifikatorlar
Iqtiboslar va manbalar
2 ta iqtibos0 ta foydalanilgan manba